Weng L, Tang W, Wang X, Gong Y, Liu C, Hong N, et al. Surplus fatty acid synthesis increases oxidative stress in adipocytes and lnduces lipodystrophy. Nat Commun. 2024;15:133 pubmed publisher

Zhang G, Jiang P, Tang W, Wang Y, Qiu F, An J, et al. CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Mol Cell. 2023;83:4370-4385.e9 pubmed publisher

Yan G, Dai M, Poulet S, Wang N, Boudreault J, Daliah G, et al. Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance. Oncogenesis. 2023;12:51 pubmed publisher

Khaleafi R, Železnjak J, Cordela S, Drucker S, Rovis T, Jonjic S, et al. Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality. Front Immunol. 2023;14:1231782 pubmed publisher

Alborzinia H, Chen Z, Yildiz U, Freitas F, Vogel F, Varga J, et al. LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO Mol Med. 2023;:e18014 pubmed publisher

Wong S, Tey S, Mao X, Fung H, Xiao Z, Wong D, et al. Small Extracellular Vesicle-Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma. Adv Sci (Weinh). 2023;10:e2302677 pubmed publisher

Cheng F, Ji Q, Wang L, Wang C, Liu G, Wang L. Reducing oxidative protein folding alleviates senescence by minimizing ER-to-nucleus H2 O2 release. EMBO Rep. 2023;:e56439 pubmed publisher

Collora J, Ho Y. Integration site-dependent HIV-1 promoter activity shapes host chromatin conformation. Genome Res. 2023;33:891-906 pubmed publisher

Gordon E, Wright C, James M, Cooper S. Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance. BMC Cancer. 2023;23:524 pubmed publisher

Zhang H, Yan J, Lu Z, Zhou Y, Zhang Q, Cui T, et al. Deep sampling of gRNA in the human genome and deep-learning-informed prediction of gRNA activities. Cell Discov. 2023;9:48 pubmed publisher

Sun G, Zheng Y, Fu X, Zhang W, Ren J, Ma S, et al. Single-cell transcriptomic atlas of mouse cochlear aging. Protein Cell. 2023;14:180-201 pubmed publisher

W xfc nnemann F, Fotsing Tadjo T, Beaudoin M, Lalonde S, Lo K, Kleinstiver B, et al. Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells. PLoS Genet. 2023;19:e1010680 pubmed publisher

Wang Y, Zhao Y, Guo W, Yadav G, Bhaskarla C, Wang Z, et al. Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Sci Adv. 2022;8:eadd0005 pubmed publisher

Tatsumi A, Hirakochi H, Inoue S, Tanaka Y, Furuno H, Ikeda M, et al. Identification of NRAS Downstream Genes with CRISPR Activation Screening. Biology (Basel). 2022;11: pubmed publisher

Koyanagi A, Onishi I, Muraoka K, Sato I, Sato S, Kimura T, et al. Identification of the Factor That Leads Human Mesenchymal Stem Cell Lines into Decellularized Bone. Bioengineering (Basel). 2022;9: pubmed publisher

Rebsamen M, Girardi E, Sedlyarov V, Scorzoni S, Papakostas K, Vollert M, et al. Gain-of-function genetic screens in human cells identify SLC transporters overcoming environmental nutrient restrictions. Life Sci Alliance. 2022;5: pubmed publisher

Dale K, Armond J, Hynds R, Vladimirou E. Modest increase of KIF11 expression exposes fragilities in the mitotic spindle, causing chromosomal instability. J Cell Sci. 2022;135: pubmed publisher

Tanaka Y, Kambayashi H, Yamamoto A, Onishi I, Sugita K, Matsumura M, et al. Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings. Int J Mol Sci. 2022;23: pubmed publisher

Dorado Garc xed a H, Pusch F, Bei Y, von Stebut J, Ib xe1 xf1 ez G, Guillan K, et al. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma. Nat Commun. 2022;13:4297 pubmed publisher

Le Nabec A, Blotas C, Briset A, Collobert M, Ferec C, Moisan S. 3D Chromatin Organization Involving MEIS1 Factor in the cis-Regulatory Landscape of GJB2. Int J Mol Sci. 2022;23: pubmed publisher

Omachi K, Miner J. Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation. PLoS ONE. 2022;17:e0270008 pubmed publisher

Saratov V, Ngo Q, Pedot G, Sidorov S, Wachtel M, Niggli F, et al. CRISPR activation screen identifies TGFβ-associated PEG10 as a crucial tumor suppressor in Ewing sarcoma. Sci Rep. 2022;12:10671 pubmed publisher

Yang H, Ting X, Geng Y, Xie Y, Nierenberg J, Huo Y, et al. The risk variant rs11836367 contributes to breast cancer onset and metastasis by attenuating Wnt signaling via regulating NTN4 expression. Sci Adv. 2022;8:eabn3509 pubmed publisher

Papes F, Camargo A, de Souza J, Carvalho V, Szeto R, LaMontagne E, et al. Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Nat Commun. 2022;13:2387 pubmed publisher

Joung J, Kirchgatterer P, Singh A, Cho J, Nety S, Larson R, et al. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Nat Commun. 2022;13:1606 pubmed publisher

Sofer S, Lamkiewicz K, Armoza Eilat S, Partouche S, Marz M, Moskovits N, et al. A genome-wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells. FASEB J. 2022;36:e22191 pubmed publisher

Hu J, Lai Y, Huang H, Ramakrishnan S, Pan Y, Ma V, et al. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis. Br J Cancer. 2022;126:57-71 pubmed publisher

King R, Lin Z, Balbin Cuesta G, Myers G, Friedman A, Zhu G, et al. SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II. Sci Adv. 2021;7:eabj5293 pubmed publisher

Evron T, Caspi M, Kazelnik M, Shor Nareznoy Y, Armoza Eilat S, Kariv R, et al. A CRISPR knockout screen reveals new regulators of canonical Wnt signaling. Oncogenesis. 2021;10:63 pubmed publisher

Jensen T, Mikkelsen N, Gao Z, Foßelteder J, Pabst G, Axelgaard E, et al. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome Res. 2021;31:2120-2130 pubmed publisher

Zhu G, Yu J, Sun Z, Chen Y, Zheng H, Lin M, et al. Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma. Cell Death Dis. 2021;12:724 pubmed publisher

Dai M, Yan G, Wang N, Daliah G, Edick A, Poulet S, et al. In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. Nat Commun. 2021;12:3055 pubmed publisher

Gu Z, Liu Y, Zhang Y, Cao H, Lyu J, Wang X, et al. Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia. Nat Genet. 2021;53:672-682 pubmed publisher

Khan O, Almagro J, Nelson J, Horswell S, Encheva V, Keyan K, et al. Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12. Nat Commun. 2021;12:2043 pubmed publisher

Chan W, Gottschalk R, Yao Y, Pomerantz J, Germain R. Efficient Immune Cell Genome Engineering with Enhanced CRISPR Editing Tools. Immunohorizons. 2021;5:117-132 pubmed publisher

Zhang H, Wen J, Bigot A, Chen J, Shang R, Mouly V, et al. Human myotube formation is determined by MyoD-Myomixer/Myomaker axis. Sci Adv. 2020;6: pubmed publisher

Song Q, Ni K, Liu M, Li Y, Wang L, Wang Y, et al. Direct-seq: programmed gRNA scaffold for streamlined scRNA-seq in CRISPR screen. Genome Biol. 2020;21:136 pubmed publisher

Hu H, Ji Q, Song M, Ren J, Liu Z, Wang Z, et al. ZKSCAN3 counteracts cellular senescence by stabilizing heterochromatin. Nucleic Acids Res. 2020;48:6001-6018 pubmed publisher

Yamamoto A, Kurata M, Onishi I, Sugita K, Matsumura M, Ishibashi S, et al. CRISPR screening identifies M1AP as a new MYC regulator with a promoter-reporter system. Peerj. 2020;8:e9046 pubmed publisher

Cai J, Chen J, Wu T, Cheng Z, Tian Y, Pu C, et al. Genome-scale CRISPR activation screening identifies a role of LRP8 in Sorafenib resistance in Hepatocellular carcinoma. Biochem Biophys Res Commun. 2020;526:1170-1176 pubmed publisher

Lin C, Mabe N, Lin Y, Yang W, Tang X, Hong L, et al. RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. Cell Death Differ. 2020;27:2234-2247 pubmed publisher

Zhao W, Yan W, Chen D, Dai L, Yang Y, Kang X, et al. Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. Am J Cancer Res. 2019;9:1183-1200 pubmed

Wiel C, Le Gal K, Ibrahim M, Jahangir C, Kashif M, Yao H, et al. BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis. Cell. 2019;: pubmed publisher

Chee Y, Pahnke J, Bunte R, Adsool V, Madan B, Virshup D. Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche. Dev Cell. 2018;46:681-695.e5 pubmed publisher

Hua J, Ahmed M, Guo H, Zhang Y, Chen S, Soares F, et al. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19. Cell. 2018;174:564-575.e18 pubmed publisher

Bester A, Lee J, Chavez A, Lee Y, Nachmani D, Vora S, et al. An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell. 2018;173:649-664.e20 pubmed publisher

Alexanian M, Maric D, Jenkinson S, Mina M, Friedman C, Ting C, et al. A transcribed enhancer dictates mesendoderm specification in pluripotency. Nat Commun. 2017;8:1806 pubmed publisher

Joung J, Konermann S, Gootenberg J, Abudayyeh O, Platt R, Brigham M, et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2017;12:828-863 pubmed publisher